BiomarkerBay has started a collaboration with the group of Prof. Rudolf de Boer, Department of Experimental Cardiology, UMCG / RuG.
With
this new collaboration, a key
expert in Translational Cardiology is added to the BiomarkerBay
network. The research group focuses on cardiogenetics, looking at
novel genes involved in cardiac remodeling, fibrosis, and metabolic changes
and diabetes. Clinically, their expertise lies on echocardiography and
end stage heart failure including VAD therapy and
transplant. One major topic is the involvement of galectin-3 in
clinical heart failure and in the general population, and its role in the
pathophysiology of heart failure.
